Skip to main content
Top
Footnotes
1
Twelve transgender women of color died during the 5 year evaluation of this project.
 
Literature
1.
go back to reference Meerwijk EL, Sevelius JM. Transgender population size in the United States: a meta-regression of population-based probability samples. Am J Public Health. 2017;107(2):e1-8.CrossRef Meerwijk EL, Sevelius JM. Transgender population size in the United States: a meta-regression of population-based probability samples. Am J Public Health. 2017;107(2):e1-8.CrossRef
2.
go back to reference Mizuno Y, Frazier EL, Huang P, Skarbinski J. Characteristics of transgender women living with HIV receiving medical care in the United States. LGBT Health. 2015;2(3):228–34.CrossRef Mizuno Y, Frazier EL, Huang P, Skarbinski J. Characteristics of transgender women living with HIV receiving medical care in the United States. LGBT Health. 2015;2(3):228–34.CrossRef
3.
go back to reference Health Resources and Services Administration. Ryan White HIV/AIDS Program Annual Client-Level Data Report 2019. 2020. Health Resources and Services Administration. Ryan White HIV/AIDS Program Annual Client-Level Data Report 2019. 2020.
4.
go back to reference Rebchook G, Keatley J, Contreras R, Perloff J, Molano LF, Reback CJ, Ducheny K, Nemoto T, Lin R, Birnbaum J, Woods T, Xavier J, The SPNS Transgender Women of Color Study Group. The transgender women of color initiative: implementing and evaluating innovative interventions to enhance engagement and retention in HIV care. Am J Public Health. 2017;107(2):224–9.CrossRef Rebchook G, Keatley J, Contreras R, Perloff J, Molano LF, Reback CJ, Ducheny K, Nemoto T, Lin R, Birnbaum J, Woods T, Xavier J, The SPNS Transgender Women of Color Study Group. The transgender women of color initiative: implementing and evaluating innovative interventions to enhance engagement and retention in HIV care. Am J Public Health. 2017;107(2):224–9.CrossRef
5.
go back to reference CDC. HIV infection, risk, prevention, and testing behaviors among transgender women - national HIV behavioral surveillance, 7 cities, 2019–2020. HIV Surveillance Special Report 27, April 2021 CDC. HIV infection, risk, prevention, and testing behaviors among transgender women - national HIV behavioral surveillance, 7 cities, 2019–2020. HIV Surveillance Special Report 27, April 2021
7.
go back to reference Elifson K, Boles J, Posey E, Sweat M, Darrow W, Elsea W. Male transvestite prostitutes and HIV risk. Am J Public Health. 1993;83(2):260–2.CrossRef Elifson K, Boles J, Posey E, Sweat M, Darrow W, Elsea W. Male transvestite prostitutes and HIV risk. Am J Public Health. 1993;83(2):260–2.CrossRef
9.
go back to reference Taylor RD, Bimbi DS, Joseph HA, Margolis AD, Parsons JT. Girlfriends: evaluation of an HIV-risk reduction intervention for adult transgender women. AIDS Educ Prev. 2011;23(5):469–78.CrossRef Taylor RD, Bimbi DS, Joseph HA, Margolis AD, Parsons JT. Girlfriends: evaluation of an HIV-risk reduction intervention for adult transgender women. AIDS Educ Prev. 2011;23(5):469–78.CrossRef
10.
go back to reference Garofalo R, Johnson AK, Kuhns LM, Cotten C, Joseph H, Margolis A. Life skills: evaluation of a theory-driven behavioral HIV prevention intervention for young transgender women. J Urban Health. 2012;89(3):419–31.CrossRef Garofalo R, Johnson AK, Kuhns LM, Cotten C, Joseph H, Margolis A. Life skills: evaluation of a theory-driven behavioral HIV prevention intervention for young transgender women. J Urban Health. 2012;89(3):419–31.CrossRef
11.
go back to reference Collier KL, Colarossi LG, Hazel DS, Watson K, Wyatt GE. Healing our women for transgender women: adaptation, acceptability, and pilot testing. AIDS Educ Prev. 2015;27(5):418–31.CrossRef Collier KL, Colarossi LG, Hazel DS, Watson K, Wyatt GE. Healing our women for transgender women: adaptation, acceptability, and pilot testing. AIDS Educ Prev. 2015;27(5):418–31.CrossRef
12.
go back to reference NIH. National Library of Medicine. Healthy Divas. Improving Engagement in HIV Care for High-risk Women. Clinicaltrials.gov. First posted 3-16-17. https://clinicaltrials.gov/ct2/show/NCT03081559. Accessed 24 Apr 2021 NIH. National Library of Medicine. Healthy Divas. Improving Engagement in HIV Care for High-risk Women. Clinicaltrials.gov. First posted 3-16-17. https://​clinicaltrials.​gov/​ct2/​show/​NCT03081559.​ Accessed 24 Apr 2021
13.
go back to reference Sevelius J, Neilands TB, Dilworth S, Castro D, Johnson MO. Sheroes: feasibility and acceptability of a community-driven, group-level HIV intervention program for transgender women. AIDS Behav. 2020;24(5):1551–9.CrossRef Sevelius J, Neilands TB, Dilworth S, Castro D, Johnson MO. Sheroes: feasibility and acceptability of a community-driven, group-level HIV intervention program for transgender women. AIDS Behav. 2020;24(5):1551–9.CrossRef
14.
go back to reference Bradford J, Reisner SL, Honnold JA, Xavier J. Experiences of transgender-related discrimination and implications for health: results from the virginia transgender health initiative study. Am J Public Health. 2013;103(10):1820–9.CrossRef Bradford J, Reisner SL, Honnold JA, Xavier J. Experiences of transgender-related discrimination and implications for health: results from the virginia transgender health initiative study. Am J Public Health. 2013;103(10):1820–9.CrossRef
15.
go back to reference Xavier J, Bradford J, Hendricks M, Safford L, McKee R, Martin E, Honnold JA. Transgender health care access in virginia: a qualitative study. Int J Transgend. 2013;14(1):3–17.CrossRef Xavier J, Bradford J, Hendricks M, Safford L, McKee R, Martin E, Honnold JA. Transgender health care access in virginia: a qualitative study. Int J Transgend. 2013;14(1):3–17.CrossRef
16.
go back to reference Sevelius J, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014;47(1):5–16.CrossRef Sevelius J, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014;47(1):5–16.CrossRef
17.
go back to reference Bockting W, MacCrate C, Israel H, Mantell JE, Remien RH. Engagement and retention in HIV care for transgender women: perspectives of medical and social service providers in New York City. AIDS Patient Care STDS. 2020;34(1):16–26.CrossRef Bockting W, MacCrate C, Israel H, Mantell JE, Remien RH. Engagement and retention in HIV care for transgender women: perspectives of medical and social service providers in New York City. AIDS Patient Care STDS. 2020;34(1):16–26.CrossRef
18.
go back to reference Sevelius J, Xavier J, Chakravarty D, Keatley J, Shade S, Rebchook G, SPNS Transgender Women of Color Study Group. Correlates of Engagement in HIV Care among Transgender Women of Color in the United States of America. AIDS and Behavior (in press) Sevelius J, Xavier J, Chakravarty D, Keatley J, Shade S, Rebchook G, SPNS Transgender Women of Color Study Group. Correlates of Engagement in HIV Care among Transgender Women of Color in the United States of America. AIDS and Behavior (in press)
21.
go back to reference Myers JE, Braunstein SL, Xia Q, Scanlin K, Edelstein Z, Harriman G, Tsoi B, Andaluz A, Yu E, Daskalakis D. Redefining prevention and care: a status-neutral approach to HIV. Open Forum Infect Dis. 2018;5(6):ofy097.CrossRef Myers JE, Braunstein SL, Xia Q, Scanlin K, Edelstein Z, Harriman G, Tsoi B, Andaluz A, Yu E, Daskalakis D. Redefining prevention and care: a status-neutral approach to HIV. Open Forum Infect Dis. 2018;5(6):ofy097.CrossRef
Metadata
Title
The Orphans of the Epidemic: Transgender Women of Color
Publication date
01-07-2021
Published in
AIDS and Behavior / Issue Special Issue 1/2021
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-021-03308-7